Current investments - Mentice

Mentice develops, markets and sells turnkey medical simulators. The simulators are used to educate and train surgeons for various types of surgery and instruments. Very high growth is forecast for the medical simulation products market, because simulator-based training significantly enhances patient safety and is substantially more cost-efficient than traditional training methods.

Mentice’s clients include leading medtech companies as well as hospitals and centres of excellence worldwide like the Karolinska Hospital, Stockholm and Stanford University.

Investment year: 2006
Turnover: SEK 175m
Fund: Priveq Investment III
Ownership: 34%
CEO: Göran Malmberg
Phone: +46 31 339 94 00
Members of the Board:
Lawrence Howard (Chairman of the Board), Johann Olav Koss, Bengt Sjöholm, Magnus Hardmeier
Priveq team:
Magnus Hardmeier

For further information, please contact

Magnus Hardmeier

Partner & Executive Chairman

Phone: +46 8 459 67 62
Mobile: +46 70 888 25 44
Read more »

Magnus Hardmeier

Partner & Executive Chairman

Magnus Hardmeier is Partner and Executive Chairman. He is responsible for sourcing new investment opportunities, in which Priveq will contribute with growth and value creation as well as implement growth strategies in cooperation with other owners, the Board of Directors and management.

Magnus started working with Private Equity in 1987 and was one of the founders of Priveq in 1998. He has, among others, been responsible for the ownership in Gibeck, Hörnell, FM Mattsson Mora Group and Novaseptic. Magnus is currently a Director of the Boards of Mentice and Metenova and Deputy of the Boards of Danfo, Nordic Room Improvement, Omegapoint and Scanmast.

Prior to Priveq, Magnus worked with Private Equity at Företagskapital and at Wallenius Lines as Controller.

He holds a B.Sc. in Business Administration from the Stockholm School of Economics and has also studied at McGill University in Montreal.